期刊文献+

慢性肾脏疾病患者血脂变化的临床意义 被引量:1

下载PDF
导出
摘要 目的:探讨脂质代谢紊乱对慢性肾脏疾病(chronic kidney disease,CKD)患者肾功能的影响。方法:回顾性调查分析131例慢性肾脏疾病患者的血脂、血浆白蛋白、肾功能情况,肾功能按内生肌酐清除率分为5组,比较不同程度的慢性肾脏损害的血脂、血浆白蛋白水平。结果:不同肾功能水平相比,血脂、血浆白蛋白水平存在显著差别;总胆固醇、甘油三酯、低密度脂蛋白胆固醇水平与内生肌酐清除率下降正相关(r值和P值分别为0.119,<0.01;0.354,<0.01;0.120,<0.01),高密度脂蛋白胆固醇及血浆白蛋白水平与内生肌酐清除率下降负相关(r值和P值分别为-0.343,<0.01;-0.246,<0.01)。CKD3期患者的脂质代谢紊乱与CKD5期相比无显著性差异。结论:随着肾功能恶化的进展,脂质紊乱和低蛋白血症越严重。在肾功能恶化进展至CKD3期之前,应给予降脂治疗,有助于改善患者的肾功能。
作者 周宏 张浩
出处 《长治医学院学报》 2009年第1期38-41,共4页 Journal of Changzhi Medical College
  • 相关文献

参考文献13

  • 1Wheeler DC. Lipids - Whatis the evidence for their role in progressive renal diease[J]. Nephrol Dia Transplant, 1995,10:14 - 16.
  • 2Executive Summary of the third report of the national cholesterol education program (NECP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adult treatment panel Ⅲ) [J]. JAMA,2001,285(19) :2486 - 2497.
  • 3Abrass CK. Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol, 2004,24( 1 ) :46 - 53.
  • 4Jun - ichi Sano,Shiro Shirakura,Shoji Oda, et al. Foam cells generated by a combination of hyperglycemia and hyperlipemia in rats. Pathol Int,2004,54(12) :904 - 913.
  • 5Muntner P,Coresh J,Smith C, et al. Plasma lipids and risk of developing renal dysfunction:The Atherosclerosis Risk in Communities Study. Kidney Int, 2000,58, ( 1 ) : 293 - 301.
  • 6Crook Errol D MD,Thallapureddy Anantha MD,Migdal Stephen MD, et al. Lipid Abnormalities and Renal Disease: Is Dyshpidemia a Predictor of Progression of Renal Disease. Am J Med Sci, 2003,325 (6) : 340 - 348.
  • 7Xiong Z. Ruan, John F. Moorhead, Jian L. Tao, Mechanisms of Dysregulation of Low - Density Lipoprotein Receptor Expression in Vascular Smooth MuscleCells by Inflammatory Cytokines. Arterioscler. Thromb. Vasc. Biol, 2006,26, (5) : 1150 - 1155.
  • 8Scheuer H,Gwinner W,Hohbach J, et al. Oxidant stress in hyperlipidemia - induced renal damage. Am J Physiol Renal Physiol, 2000,278( 1 ) :F63 - F74.
  • 9Chen J,Muntner P,Hamm LL,et al.The metabolic syndrome and chronic kidney disease in US adults. Ann lntem Med,2004, 140(3): 167- 174.
  • 10Kawamoto S, Kawamura T,Miyazaki Y, et al. Effects of atorvastatin on hyperlipidemia in kidney disease patients. Nippon Jinzo Gakkai Shi ,2007,49( 1 ) :41 - 48.

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部